Treatment outcomes of 156 patients with cervical esophageal cancers treated with definitive radiation therapy- A single-institution experience of a rare cancer
机构:[1]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.[2]Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.[3]Department of Orthopedics, TongRen Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.[4]Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University, Shanghai, China.
National Natural Science Foundation of China (grant
number: 21172043), PI: KZ. National Natural Science
Foundation of China (grant number: 21441010), PI: KZ.
National Natural Science Foundation of China (grant number:
81872454), PI: KZ. Key Technologies Research and Development
Program (grant number: 2016YFC1303200), PI: KZ
第一作者机构:[1]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.[2]Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
共同第一作者:
通讯作者:
通讯机构:[1]Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.[2]Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
推荐引用方式(GB/T 7714):
Zhang Xiaofei,Fang Xumeng,Liu Peiyi,et al.Treatment outcomes of 156 patients with cervical esophageal cancers treated with definitive radiation therapy- A single-institution experience of a rare cancer[J].FRONTIERS IN ONCOLOGY.2022,12:doi:10.3389/fonc.2022.929583.
APA:
Zhang Xiaofei,Fang Xumeng,Liu Peiyi,Liu Di,Yang Huanjun...&Zhao Kuaile.(2022).Treatment outcomes of 156 patients with cervical esophageal cancers treated with definitive radiation therapy- A single-institution experience of a rare cancer.FRONTIERS IN ONCOLOGY,12,
MLA:
Zhang Xiaofei,et al."Treatment outcomes of 156 patients with cervical esophageal cancers treated with definitive radiation therapy- A single-institution experience of a rare cancer".FRONTIERS IN ONCOLOGY 12.(2022)